Danaparoid (Orgaran) Assay
Danaparoid is a heparinoid substitute that is used in patients that have Heparin Induced Thrombocytopaenia.
| Tube | 05 (CP) - Citrate |
|---|---|
| ID | 12728 |
| Availability | Weekdays |
| Additional Information | Danaparoid active components consist of heparin sulphate, dermatan sulphate, and chondroitin sulphate. Danaparoid differs from other low molecular weight heparins in that Danaparoid is devoid of heparin or heparin fragments. Similarly to LMWH's, it exerts its antithrombotic effect principally through anti-thrombin mediated inhibition of factor Xa, and to a much lesser extent, thrombin. |
| Send to | Specialist Coagulation Chancellor / Lincoln Wing Link Corridor Pathology Block 32 St James University Hospital Beckett Street Leeds LS9 7TF |
| Contact | https://www.leedsth.nhs.uk/a-z-of-services/pathology-2/specialist-laboratory-medicine-slm/specialist-coagulation/?stage=Stage |
| Collection Con | 1 x Citrate tube filled to the line. Samples must be processed within 6 hours of being taken. |
| Sample REQ | Blood |
| Ref. Range Notes | Critical telephone values: Danaparoid levels greater than 1.5IU/mL Interpreted against a therapeutic range dependant on clinical details |
| Units | iu/mL |
| IP Acute TAT | 4 hours from receipt |
| IP Routine TAT | 24 hours |
| GP Acute TAT | Contact laboratory |
| GP Routine TAT | 2-8 days |
| Telepath | DAN1J |
| ICE Codes | LDAN |
